Unknown

Dataset Information

Examining association between cohesion and diversity in collaboration networks of pharmaceutical clinical trials with drug approvals.


ABSTRACT:

Objective

Clinical trials ensure that pharmaceutical treatments are safe, efficacious, and effective for public consumption, but are extremely complex, taking up to 10 years and $2.6 billion to complete. One main source of complexity arises from the collaboration between actors, and network science methodologies can be leveraged to explore that complexity. We aim to characterize collaborations between actors in the clinical trials context and investigate trends of successful actors.

Materials and methods

We constructed a temporal network of clinical trial collaborations between large and small-size pharmaceutical companies, academic institutions, nonprofit organizations, hospital systems, and government agencies from public and proprietary data and introduced metrics to quan

SUBMITTER: Lin G 

PROVIDER: S-EPMC7810455 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature